Data / Form D filings / Elicio Therapeutics, Inc.
Elicio Therapeutics, Inc.: Form D filings
Elicio Therapeutics, Inc., a biotechnology company in Boston, MA, filed 8 Form D notices with the SEC between 2015 and 2024. The latest, on March 29, 2024, reports $6 million sold of a $6 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 451 D STREET, 5TH FLOOR, Boston, MA, 02210
- Phone
- (857) 209-0050
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1601485
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 29, 2024 | New notice | $6,000,000 | $6,000,000 | 1 | Mar 19, 2024 | sec.gov | |
| Jan 5, 2024 | New notice | $7,047,530 | $7,047,530 | 1 | Dec 22, 2023 | sec.gov | |
| Jun 23, 2020 | New notice | $40,000,000 | $6,695,000 | $33,305,000 | 54 | Jun 12, 2020 | sec.gov |
| Jan 27, 2020 | New notice | $12,000,000 | $1,000,000 | $11,000,000 | 7 | Jan 14, 2020 | sec.gov |
| Jan 13, 2020 | New notice | $12,000,000 | $6,081,980 | $5,918,020 | 51 | Dec 24, 2019 | sec.gov |
| Jul 17, 2018 | New notice | $35,000,000 | $15,379,000 | $19,621,000 | 133 | Jul 5, 2018 | sec.gov |
| Jul 17, 2018 | New notice | $5,438,891 | $5,438,891 | 18 | Jan 11, 2017 | sec.gov | |
| Feb 20, 2015 | New notice | $15,000,000 | $4,356,452 | $10,643,548 | 23 | Jan 7, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Yekaterina Chudnovsky | Director | |
| Karen Wilson | Director | |
| Christopher Haqq | Executive Officer | |
| Jay Venkatesan | Director | |
| Carol Ashe | Director | |
| Brian Piekos | Executive Officer | |
| Robert Connelly | Executive Officer, Director | |
| Allen Nissenson | Director | |
| Robert Ruffolo | Director | |
| Peter DeMuth | Executive Officer | |
| Julian Adams | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Mar 25, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Elicio Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.